Video

Dr. Saba Discusses Ongoing Trials in Head and Neck Cancer

Nabil F. Saba, MD, FACP, discusses ongoing clinical trials in head and neck cancer.

Nabil F. Saba, MD, FACP, director, Head and Neck Medical Oncology Program, Winship Cancer Institute of Emory University, professor, Department of Hematology and Medical Oncology, Department of Otolaryngology, Emory University School of Medicine, discusses ongoing clinical trials in head and neck cancer.

Currently, ongoing trials are evaluating combination regimens with immunotherapy in head and neck cancer, says Saba. Additionally, data from trials investigating EGFR inhibitors plus checkpoint inhibitors are maturing.

Other trials have demonstrated promising findings with TKIs, such as lenvatinib (Lenvima), plus checkpoint inhibitors, such as pembrolizumab (Keytruda), in head and neck cancer, as well as thyroid cancer, Saba explains.

Human papillomavirus vaccines in combination with PD-1 inhibitors, as well as intratumoral injections that can alter the tumor microenvironment are also under evaluation, says Saba. Specifically, ongoing trials are exploring the potential role of STING agonists in boosting the local immune microenvironment and anti-immune effect of PD-1 inhibitors in patients with head and neck cancer, concludes Saba.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation
Video

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Jun 6th 2025 - Jul 12th 2025

online-activity
Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC
Video

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

Jun 6th 2025 - Jul 12th 2025

online-activity
Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing
Video

Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing

Jun 5th 2025 - Jul 12th 2025

online-activity